Molecular and genetic bases for maturity onset diabetes of youth

Current Opinion in Pediatrics

Volumn 12, Issue 4, 2000, Pages 388-393

  Winter, William E ^a   Silverstein, Janet H ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; NUCLEAR FACTOR; TRANSCRIPTION FACTOR;

AUTOSOMAL DOMINANT DISORDER; B LYMPHOCYTE; CHILD; GENE EXPRESSION; GENE MUTATION; HUMAN; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; DIABETES MELLITUS, TYPE 2; GLUCOKINASE; HEPATOCYTES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MOLECULAR BIOLOGY; MUTATION; PHENOTYPE; PREVALENCE; TRANSCRIPTION FACTORS;

EID: 0033940888     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200008000-00019     Document Type: Review

References (44)

1. 1 Expert Committee: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999, 22(Suppl 1):5-19. This article provides a cogent summary of the latest recommendations from the American Diabetes Association on the diagnosis and classification of diabetes mellitus. As of year 2000, diabetes is classified according to etiology and not treatment. Since 1997, the diagnostic cut point for hyperglycemia has been lowered to 126 mg/dL.
2. 2 Winter WE, Nakamura M, House DV: Monogenic diabetes mellitus in youth: the MODY syndromes. Endocrinol Metabol Clin North Am 1999, 28:765-785.
3. 3 Fajans SS: Scope and heterogeneous nature of MODY. Diabetes Care 1990, 13:49-64.
4. 4 Winter WE, Maclaren NK, Riley WJ, et al.: Maturity onset diabetes of youth in black Americans. New Engl J Med 1987, 316:285-291.
5. 5 Sander M, German M: The βcell transcription factors and development of the pancreas. J Mol Med 1997, 75:327-340.
6. 6 Habener JF, Stoffers DA: A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. Proc Ass Am Phys 1998, 110:12-21.
7. 7 Madsen OD, Jensen J, Petersen HV, et al: Transcription factors contributing to the pancreatic βcell phenotype. Horm Metab Res 1997, 29:265-270.
8. 8 Vaisse C, Kim J, Espinosa R, et al.: Pancreatic islet expression studies and polymorphic DNA markers in the genes encoding hepatocyte nuclear factor-3α, -3β, -3γ, -4γ, and 6. Diabetes 1997, 46:1364-1367.
9. 9 Bulman MP, Dronsfield MJ, Frayling T. et al.: A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturityonset diabetes of the young. Diabetologia 1997, 40:859-862.
10. 10 Lindner T, Gragnoli C, Furuta H, et al.: Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4α/MODY1 gene J Clin Inv 1997, 100:1400-1405.
11. 11 Lehto M, Bitzén PO, Isomaa B, et al.: Mutation in the HNF-4α gene affects insulin secretion and triglyceride metabolism. Diabetes 1999, 48:423-425.
12. 12 Furuta H, Iwasaki N, Oda N, et al.: Organization and partial sequence of the hepatocyte nuclear factor-4α/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes 1997, 46:1652-1657.
13. 13 Iwasaki N, Ogata M, Tomonaga O, et al.: Liver and kidney function in Japanese patients with maturityonset diabetes of the young. Diabetes Care 1998, 21:2144-2148.
14. 14 Moøller AM, Urhammer SA, Dalgaard LT, et al.: Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4α in Caucasians with maturity onset NIDDM. Diabetologia 1997, 40:980-983.
15. 15 Møller AM, Dalgaard LT, Ambye L, et al.: A novel Phe75fsdelT mutation in the hepatocyte nuclear factor-4α gene in a Danish pedigree with maturityonset diabetes of the young. J Clin Endo Metabol 1999, 84:367-369.
16. 16 Bell GI, Xiang KS, Newman MVD, et al.: Gene for noninsulindependent diabetes mellitus (maturityonset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci U S A 1991, 88:1484-1488.
17. 17 Malecki MT, Antonellis A, Casey P, et al.: Exclusion of the hepatocyte nuclear factor 4α as a candidate gene for lateonset NIDDM linked with chromosome 20q. Diabetes 1998, 47:970-972.
18. 18 Stoffers DA, Zinkin NT, Stanojevic V, et al.: Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Gen 1997, 15:106-110.
19. 19 Horikawa Y, Iwasaki N, Hara M, et al.: Mutation in hepatocyte nuclear factor 1β gene (TCF2) associated with MODY. Nat Gen 1997, 17:384-385.
20. 20 Nishigori H, Yamada S, Kohama T, et al.: Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor 1β gene associated with diabetes and renal dysfunction. Diabetes 1998, 47:1354-1355.
21. 21 Iwasaki N, Oda N, Ogata M, et al.: Mutations in the hepatocyte nuclear factor-1alpha/MODY3 gene in Japanese subjects with early and lateonset NIDDM. Diabetes 1997, 46:1504-1508.
22. 22 Elbein SC, Teng K, Yount P, et al.: Linkage and molecular scanning analyses of MODY3/hepatocyte nuclear factor-1α gene in typical familial type 2 diabetes: evidence for novel mutations in exons 8 and 10. J Clin Endo Metabol 1998, 83:2059-2065.
23. 23 Matschinsky FM: A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996, 45:223-241.
24. 24 Matschinsky FM, Glaser B, Magnuson MA: Pancreatic βcell glucokinase, closing the gap between theoretical concepts and experimental realities. Diabetes 1998, 47:307-315.
25. 25 Froguel P, Zouali H, Vionnet N, et al.: Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med 1993, 328:697-702.
26. 26 Nakamura M, House DV, Winter WE: Novel mutation identified in the glucokinase (GCK) genes of a patient with atypical diabetes mellitus (ADM) of African Americans [abstract]. Diabetes 1996, 45(Suppl 2):76.
27. 27 Nakamura M, House DV, Winter WE: A novel homoplasmic point mutation at mitochondrial DNA (mtDNA) nucleotide 3308 in a family with atypical diabetes mellitus (ADM) of African Americans (AA) [abstract]. Diabetes 1997, 46(Suppl 1):175.
28. 28 Nakamura M, House DV, Winter WE: The insulin gene in atypical diabetes mellitus (ADM): no evidence for exon 2 mutations [abstract]. Diabetes 1997, 46(Suppl 1):177.
29. 29 Wang JC, Stafford JM, Granner DK: SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. J Biol Chem 1998, 273:30847-30850.
30. 30 Suaud L, Hemimou Y, Formstecher P, et al.: Functional study of the E276Q mutant hepatocyte nuclear factor-4α found in type 1 maturity-onset diabetes of the young. Diabetes 1999, 48:1162-1167.
31. 31 Burke CV, Buettger CW, Davis EA, et al.: Cell biologic assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinemia (GK-HI). Biochem J 1999, 342:345-352.
32. 32 Miller SP, Anand GR, Karschnia EJ, et al.: Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2). Diabetes 1999, 48:1645-1651.
33. 33 Møller AM, Dalgaard LT, Pociot F, et al.: Mutations in the hepatocyte nuclear factor-1α gene in Caucasian families originally classified as having type I diabetes. Diabetologia 1998, 41:1528-1531.
34. 34 Menzel R, Kaisaki PJ, Rjasanowski I, et al.: A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1α(HNF-1α) gene. Diabetic Med 1998, 15:816-820.
35. 35 Lee BC, Appleton M, Shore AC, et al.: Impaired maximum microvascular hyperaemia in patients with MODY3 hepatocyte nuclear factor gene mutations). Diabetic Med 1999, 16:731-735.
36. 36 Okita K, Yang Q, Yamagata K, et al.: Human insulin gene is a target gene of hepatocyte nuclear factor-1α (HNF-1α) and HNF-1β. Biochem Biophys Res Commun 1999, 263:566-569.
37. 37 Lehto M, Wipemo C, Ivarsson SA, et al.: High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes. Diabetologia 1999, 42:1131-1137.
38. 38 Chèvre JC, Hani EH, Boutin P, et al.: Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia 1998, 41:1017-1023.
39. 39 Doria A, O'Keeffe C, Yang Y, et al.: Phenotypic characteristics of earlyonset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes. Diabetes Care 1999, 22:253-261.
40. 40 Furuta H, Horikawa Y, Iwaski N, et al.: β Cell transcription factors and diabetes. Diabetes 1998, 47:1356-1358.
41. 41 Møller AM, Ek J, Durviaux SM, et al.: Hepatocyte nuclear factor-6: associations between genetic variability and type II diabetes and genetic variability and estimates of insulin secretion. Diabetologia 1999, 42:1011-1016.
42. 42 Dupont S, Vionnet N, Chèvre JC, et al.: No evidence of linkage or diabetes-associated mutations in the transcription factors BETA2/NEUROD1 and PAX4 in type II diabetes in France. Diabetologia 1999, 42:480-484.
43. 43 Lindner TH, Cockburn BN, Bell GI: Molecular genetics of MODY in Germany. Diabetologia 1999, 42:121-123.
44. 44 Guazzarotti L, Bartolotta E, Chiarelli F: Maturity-onset diabetes of the young (MODY): a new challenge for pediatric diabetologists. J Pediatr Endocrinol Metab 1999, 12:487-497. This practical article notifies pediatric endocrinologists and diabetologists that we must be aware of unusual forms of diabetes, particularly the MODY syndrome.